Is this your company? Get featured or correct your listing →
Company Snapshot
Drug Farm is a Biotech company, based in Shanghai, China / New York, NY, founded 2015.
Recent changes
- Jul 13, 2026Jul 13, 2026Raised $55M Series D FierceBiotech
- Jul 13, 2026Jul 13, 2026New investor: Shanghai Pudong Leading Area Investment Center FierceBiotech
- Jul 13, 2026Jul 13, 2026New investor: Shanghai Puxing Collaborative Private Equity Fund FierceBiotech
- Jul 13, 2026Jul 13, 2026Drug Farm Raises $55M Series D for Rare Disease Drug Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2026 | Series D | $55M | — | Pulse story |
Investors
Latest Pulse
- Jul 14, 2026What Post-H1 Funding Data Already Shows for Q3Helsing, Gauntlet and Drug Farm's rounds this week are early evidence that H1 2026's concentration pattern -- record capital, AI capturing 86%, the top five managers taking 73.1% -- is continuing into Q3, not reversing.→
- Jul 13, 2026Drug Farm Raises $55M Series D for Rare Disease DrugBiotech Drug Farm raised a $55 million Series D to advance DF-003, a Phase 3 ALPK1 inhibitor for rare autoinflammatory disorder ROSAH syndrome, alongside DF-006, a Phase 2 immunomodulator for hepatitis B and liver cancer.→
Coverage Timeline
newest firstAll Coverage
FUNDING86% AI, top 5 = 73.1%
What Post-H1 Funding Data Already Shows for Q3
Helsing, Gauntlet and Drug Farm's rounds this week are early evidence that H1 2026's concentration pattern -- record capital, AI capturing 86%, the top five managers taking 73.1% -- is continuing into Q3, not reversing.
Drug Farm Raises $55M Series D for Rare Disease Drug
FUNDING$55M Series D
Drug Farm Raises $55M Series D for Rare Disease Drug
Biotech Drug Farm raised a $55 million Series D to advance DF-003, a Phase 3 ALPK1 inhibitor for rare autoinflammatory disorder ROSAH syndrome, alongside DF-006, a Phase 2 immunomodulator for hepatitis B and liver cancer.
Related Companies
Drug Farm FAQ
Who are Drug Farm's investors?
Drug Farm's investors include Shanghai Pudong Leading Area Investment Center, Shanghai Puxing Collaborative Private Equity Fund, Betta Capital, BioVeda China Fund, Detong Capital, and 3 more (As of 2026-07-31T14:35:19Z).
Sources & methodologyshow
Where these figures come from
- FierceBiotechmajor outlet1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.